Barbara Ryan's most recent trade in MiNK Therapeutics Inc was a trade of 1,601 Common Stock done at an average price of $11.1 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 11.09 per share. | 01 Dec 2025 | 1,601 | 22,406 | - | 11.1 | 17,755 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2025 | 3,225 | 3,225 | - | - | Stock Option (Right to Buy) | |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 13.86 per share. | 02 Sep 2025 | 1,281 | 20,805 | - | 13.9 | 17,755 | Common Stock |
| NAYA Biosciences | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 45,000 | 45,157 | - | - | Stock Option (right to buy) | |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 7.17 per share. | 02 Jun 2025 | 2,476 | 19,524 | - | 7.2 | 17,753 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 8.79 per share. | 03 Mar 2025 | 2,019 | 17,048 | - | 8.8 | 17,747 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.73 per share. | 01 Dec 2024 | 24,229 | 150,336 | - | 0.7 | 17,687 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.82 per share. | 03 Sep 2024 | 21,649 | 126,107 | - | 0.8 | 17,752 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 03 Jun 2024 | 17,841 | 104,458 | - | 1.0 | 17,663 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.95 per share. | 01 Mar 2024 | 18,685 | 86,617 | - | 1.0 | 17,751 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 01 Dec 2023 | 17,068 | 67,932 | - | 1.0 | 17,751 | Common Stock |
| NAYA Biosciences | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 2.09 per share. | 01 Mar 2023 | 8,493 | 28,844 | - | 2.1 | 17,750 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 2.61 per share. | 01 Dec 2022 | 6,801 | 20,351 | - | 2.6 | 17,751 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 15 Sep 2022 | 13,550 | 13,550 | - | 2.6 | 35,501 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| NAYA Biosciences | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 10,435 | 10,435 | - | - | Stock Option | |
| NAYA Biosciences | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 8,588 | 21,053 | - | 0 | Common Stock |